Skip to main content
Equibles

HRT FINANCIAL LP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1475597 NEW YORK, NY
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,843,277
+$17,563,468 QoQ
Shares Held
368,510
+111.1% QoQ
Ownership
0.325%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#64
of 667 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. HALO ranks #9 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,089,376 $81,136,724
2 INSM
INSMED Inc
 689,981 $73,565,774
3 EXEL
Exelixis, Inc.
 929,242 $50,560,057
4 MDGL
Madrigal Pharmaceuticals, Inc.
 84,634 $45,444,226
5 AXSM
Axsome Therapeutics, Inc.
 178,491 $43,689,242
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 498,655 $40,645,369
7 ABVX
Abivax S.A.
 270,612 $36,061,755
8 TGTX
Tg Therapeutics, Inc.
 622,603 $34,205,808

All Filings in HALO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,843,277 368,510
2026-03-31 $11,279,809 174,529
2025-09-30 $17,642,450 240,557
2025-06-30 $24,296,981 467,070
2025-03-31 $4,408,313 69,085
2024-06-30 $479,355 9,155
2023-12-31 $2,894,633 78,318
2023-09-30 $3,129,878 81,934
2023-06-30 $1,147,278 31,807
2023-03-31 $2,811,891 73,629
2022-12-31 $3,559,777 62,562
2022-09-30 $701,637 17,745
2022-06-30 $3,448,456 78,374
2021-12-31 $1,429,344 35,547
2021-03-31 $879,325 21,092